Full-Time
Develops RNA-based medicines and therapies
No salary listed
Expert
Cambridge, MA, USA
Upload your resume to see how it matches 2 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Orbital Therapeutics develops RNA-based medicines, focusing on areas like vaccines, immunomodulation, and protein replacement. The company utilizes RNA technology, advanced delivery methods, data science, and automation to create a platform for a wide range of therapeutic applications. Unlike many competitors, Orbital Therapeutics specifically excludes small interfering RNA from its focus, allowing it to carve out a unique niche in the genetic medicine space. The goal is to enhance global health by harnessing RNA medicines to treat diseases in innovative ways that were not possible before. Revenue is generated through the sale of these medicines to healthcare providers who administer them to patients.
Company Size
51-200
Company Stage
Series A
Total Funding
$270M
Headquarters
San Francisco, California
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Orbital Therapeutics appoints Geno Germano, biopharma veteran, to its Board of Directors.
Orbital Therapeutics appoints Anna Dixon as senior vice president, human resources.
Orbital Therapeutics appoints veteran biopharma leader, Ron Philip, as chief executive officer.
Orbital Therapeutics, a company focused on enhancing global health by unleashing the full potential of RNA medicines to treat human disease, today ann
Orbital is developing an RNA platform that can combine well-known and upcoming RNA technologies and delivery systems.